Literature DB >> 30962001

Rediscovering MIF: New Tricks for an Old Cytokine.

James Harris1, Sonya VanPatten2, Nadia S Deen3, Yousef Al-Abed2, Eric F Morand3.   

Abstract

Produced by many cell types, macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with critical and supporting roles in many disease states and conditions. Its disease associations, myriad functions, receptors, and downstream signaling have been the subject of considerable research, yet many questions remain. Moreover, the relevance of MIF's partially functionally redundant family member, D-dopachrome tautomerase (D-DT), also remains to be further characterized. Here, we discuss recent discoveries demonstrating direct roles of MIF in supporting NLR Family Pyrin Domain-Containing 3 (NRLP3) inflammasome activation, as well as acting as a molecular chaperone for intracellular proteins. These findings may offer new clues to understanding MIF's multiple functions, and assist the development of putative MIF-targeting therapeutics for a variety of pathologies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 30962001     DOI: 10.1016/j.it.2019.03.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  20 in total

Review 1.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

2.  The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF).

Authors:  Fumi Varyani; Stephan Löser; Kara J Filbey; Yvonne Harcus; Claire Drurey; Marta Campillo Poveda; Orhan Rasid; Madeleine P J White; Danielle J Smyth; François Gerbe; Philippe Jay; Rick M Maizels
Journal:  Mucosal Immunol       Date:  2022-03-14       Impact factor: 7.313

3.  Association of Macrophage Migration Inhibitory Factor Gene -173 G/C Polymorphism (rs755622) with Familial Mediterranean Fever in Children.

Authors:  Nursen Cakan; Resul Yılmaz; Erhan Karaaslan; Ömer Ateş
Journal:  J Pediatr Genet       Date:  2020-11-25

4.  TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages.

Authors:  Pengyu Zong; Jianlin Feng; Zhichao Yue; Albert S Yu; Jean Vacher; Evan R Jellison; Barbara Miller; Yasuo Mori; Lixia Yue
Journal:  Nat Cardiovasc Res       Date:  2022-03-28

5.  Mitochondrial DNA alterations in aged macrophage migration inhibitory factor-knockout mice.

Authors:  Allen Herbst; Austin N Hoang; Wendy Woo; Debbie McKenzie; Judd M Aiken; Richard A Miller; David B Allison; Nianjun Liu; Jonathan Wanagat
Journal:  Mech Ageing Dev       Date:  2019-08-02       Impact factor: 5.432

6.  Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite.

Authors:  Kara J Filbey; Fumi Varyani; Yvonne Harcus; James P Hewitson; Danielle J Smyth; Henry J McSorley; Alasdair Ivens; Susanne Nylén; Martin Rottenberg; Stephan Löser; Rick M Maizels
Journal:  Front Immunol       Date:  2019-10-24       Impact factor: 7.561

7.  MiMIF-2 Effector of Meloidogyne incognita Exhibited Enzyme Activities and Potential Roles in Plant Salicylic Acid Synthesis.

Authors:  Jianlong Zhao; Zhenchuan Mao; Qinghua Sun; Qian Liu; Heng Jian; Bingyan Xie
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 8.  Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair.

Authors:  Laura Farr; Swagata Ghosh; Shannon Moonah
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 9.  Parasite-Produced MIF Cytokine: Role in Immune Evasion, Invasion, and Pathogenesis.

Authors:  Swagata Ghosh; Nona Jiang; Laura Farr; Renay Ngobeni; Shannon Moonah
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

10.  Targeting Parasite-Produced Macrophage Migration Inhibitory Factor as an Antivirulence Strategy With Antibiotic-Antibody Combination to Reduce Tissue Damage.

Authors:  Swagata Ghosh; Jay Padalia; Renay Ngobeni; Jan Abendroth; Laura Farr; Debbie-Ann Shirley; Thomas Edwards; Shannon Moonah
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.